Evidence map›Paper›PMID 28401384›Full record

SynthesisCurrent rheumatology reports2017

Bone Involvement in Rosai-Dorfman Disease (RDD): a Case Report and Systematic Literature Review.

Birgit A Mosheimer, Bastian Oppl, Shahin Zandieh, Michael Fillitz, Felix Keil, Klaus Klaushofer, Günter Weiss, Jochen Zwerina

Open access · hybridAbstract readCase ReportsSystematic Review
In one paragraph

Synthesis in Current rheumatology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Rosai-Dorfman Disease Presenting with Knee Arthralgia.Internal medicine (Tokyo, Japan) · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Rosai-Dorfman disease in a symptomatic elderly man.Proceedings (Baylor University. Medical Center) · 2022
    Article
  15. Article
  16. Potential role ofAsia Oceania journal of nuclear medicine & biology · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Birgit A MosheimerDepartment of Internal Medicine VI, Infectious Diseases, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, Anichstrasse 35, Innsbruck, Austria. birgit.mosheimer@i-med.ac.at.
Bastian OpplLudwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Vienna, Austria.
Shahin ZandiehInstitute of Radiology and Nuclear Medicine, Hanusch Hospital, Vienna, Austria.
Michael Fillitz3rd Medical Department, Hanusch Hospital, Vienna, Austria.
Felix Keil3rd Medical Department, Hanusch Hospital, Vienna, Austria.
Klaus KlaushoferLudwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Vienna, Austria.
Günter WeissDepartment of Internal Medicine VI, Infectious Diseases, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, Anichstrasse 35, Innsbruck, Austria.
Jochen ZwerinaLudwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Vienna, Austria.
Hanusch Hospital · ATLudwig Boltzmann Institute of Osteology · ATInnsbruck Medical University · ATUniversität Innsbruck · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewRosai-Dorfman disease (RDD) is a rare histiocytic disorder typically presenting as painless cervical lymphadenopathy. Extranodal involvement is common and may also affect bones. Here, we present a patient with typical nodal disease and multifocal bone manifestations. Further, a systematic literature review was performed to better understand the phenotype, clinical course and treatment options of such patients. RECENT

findingsRDD is a nonmalignant, classically sporadic histiocytosis. Nevertheless, increasing evidence also suggests familial forms of the disease. According to our literature review, bone involvement is exceedingly rare and heterogeneous. Clinical outcome in terms of mortality seems to be favorable in most cases. Currently, therapy strategies include surgical and immunosuppressive treatments, but the optimal treatment of osseous RDD remains to be defined. Patients with osseous RDD may present to rheumatologists with arthralgia or arthritis. Due to the rarity of the disease, diagnosis and treatment remain challenging.

Indexed as

AdultArthralgiaBone DiseasesDiagnosis, DifferentialDrug Therapy, CombinationFemaleGlucocorticoidsHandHistiocytosis, SinusHumansImmunosuppressive AgentsMagnetic Resonance ImagingRadiographyGlucocorticoidsImmunosuppressive AgentsBone involvementRosai-Dorfman diseaseTreatment strategies

Identifiers

PMID28401384
PMCPMC5388731
OpenAlexW2605855778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.